AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32043545 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpipe tobacco users who also smoke cigarettes
Number of subjects: 510
Study 32043545 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpipe tobacco users who smoke less than all day
Number of subjects: 510
Study 32043545 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age at starting smoking
Number of subjects: 510
Study 32043545 — intervention group
Group type: COMPARATOR
Intervention: No association found
Number of subjects: 510
Study 35367245 — intervention group
Group type: EXPERIMENTAL
Intervention: STRIP intervention group (heart-healthy diet with low SAFA and cholesterol, biannual counselling from 7 months to 20 years)
Number of subjects: 0
Study 34212187 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 2092
Study 34212187 — intervention group
Group type: COMPARATOR
Intervention: Standard 12-month dual antiplatelet therapy (DAPT) with aspirin and ticagrelor
Number of subjects: 2092
Study 32408065 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.45 GHz Wi-Fi (max psSAR10g of 6.4 mW/kg)
Number of subjects: 34
Study 32408065 — intervention group
Group type: COMPARATOR
Intervention: Sham signals
Number of subjects: 34
Study 35339652 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage chair used twice a day for 6 months
Number of subjects: 80
Study 35339652 — intervention group
Group type: COMPARATOR
Intervention: Control group educated about lifestyle modification
Number of subjects: 80
Study 32665039 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine 400mg orally once daily for 90 days
Number of subjects: 988
Study 32665039 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two tablets visually identical to hydroxychloroquine) orally once daily for 90 days
Number of subjects: 988
Study 33919991 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine tartrate supplementation
Number of subjects: 0
Study 33378391 — intervention group
Group type: EXPERIMENTAL
Intervention: High personalized power motive (p Power) leaders
Number of subjects: 96
Study 33378391 — intervention group
Group type: COMPARATOR
Intervention: Low personalized power motive (p Power) leaders
Number of subjects: 96
Study 33378391 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with positive changes in testosterone (T)
Number of subjects: 96
Study 616115985 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily (n=44)
Number of subjects: 88
Study 616115985 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo (n=44)
Number of subjects: 88
Study 35877933 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive application of bipolar radiofrequency energy to the affected areas.
Number of subjects: 10
Study 33920888 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated corn oil (HO)
Number of subjects: 27
Study 33920888 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,4-Decadienal (2,4-DD)
Number of subjects: 27
Study 33920888 — intervention group
Group type: COMPARATOR
Intervention: Non-heated corn oil (CO)
Number of subjects: 27
Study 32885874 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-learning (SL) group
Number of subjects: 114
Study 32885874 — intervention group
Group type: COMPARATOR
Intervention: Lecture (LS) group
Number of subjects: 114
Study 36031355 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg (group M)
Number of subjects: 120
Study 36031355 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.5 μg/kg (group H)
Number of subjects: 120
Study 36031355 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg (group L)
Number of subjects: 120
Study 36031355 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 120
Study 32019389 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance intervention (twice-weekly sessions for 8 months)
Number of subjects: 112
Study 32019389 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study 36148447 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at the sphenopalatine ganglion (SPG)
Number of subjects: 120
Study 36148447 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture (PA) at the SPG
Number of subjects: 120
Study 36148447 — intervention group
Group type: COMPARATOR
Intervention: Rescue medication (RM) only
Number of subjects: 120
Study 35804455 — intervention group
Group type: EXPERIMENTAL
Intervention: interprof ACT intervention package
Number of subjects: 34
Study 35036624 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT) once monthly for 6 months
Number of subjects: 0
Study 35036624 — intervention group
Group type: COMPARATOR
Intervention: Home Exercise (HE) for 6 months
Number of subjects: 0
Study 35036624 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 0
Study 36178481 — intervention group
Group type: EXPERIMENTAL
Intervention: MBCT plus psychoeducation
Number of subjects: 148
Study 36178481 — intervention group
Group type: COMPARATOR
Intervention: STEP
Number of subjects: 148
Study 33574445 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall of negative events (mild reinforcement of stress or fear/anxiety)
Number of subjects: 4889
Study 33574445 — intervention group
Group type: COMPARATOR
Intervention: Control group (recall of neutral or joyful memories)
Number of subjects: 4889
Study 32709183 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 kHz high-frequency spinal cord stimulation (HF-SCS)
Number of subjects: 19
Study 36146310 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 h in bed (03:00‐08:00 h)
Number of subjects: 41
Study 36146310 — intervention group
Group type: COMPARATOR
Intervention: 9 h in bed (23:00‐08:00 h)
Number of subjects: 41
Study 33275162 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT
Number of subjects: 224
Study 33275162 — intervention group
Group type: COMPARATOR
Intervention: PAHG
Number of subjects: 224
Study 33544206 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 g/d native inulin (prebiotic)
Number of subjects: 24
Study 33544206 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (placebo)
Number of subjects: 24
Study 32501247 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical component ride value for road profile 1
Number of subjects: 10
Study 32501247 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical component ride value for road profile 2
Number of subjects: 10
Study 32501247 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined point ride value for road profile 1
Number of subjects: 10
Study 32501247 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined point ride value for road profile 2
Number of subjects: 10
Study 32501247 — intervention group
Group type: COMPARATOR
Intervention: Comparison of medians of the relative difference threshold over the two roads
Number of subjects: 10
Study 32205547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleth Variability Index (PVI) group
Number of subjects: 438
Study 32205547 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard management strategy)
Number of subjects: 438
Study 35570386 — intervention group
Group type: EXPERIMENTAL
Intervention: MARSI nursing management (risk assessment, risk prevention, and risk management)
Number of subjects: 156
Study 35570386 — intervention group
Group type: EXPERIMENTAL
Intervention: MARSI nursing management
Number of subjects: 156
Study 35570386 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing care (control group)
Number of subjects: 156
Study 33017630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate education level
Number of subjects: 12315
Study 33017630 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced education level
Number of subjects: 12315
Study 33017630 — intervention group
Group type: EXPERIMENTAL
Intervention: Education (general)
Number of subjects: 12315
Study 35987728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod
Number of subjects: 0
Study 35987728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33494132 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia juice (AJ) with 1177.11 mg polyphenols/100 mL (n = 22)
Number of subjects: 62
Study 33494132 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia juice (MJ) with 294.28 mg polyphenols/100 mL (n = 20)
Number of subjects: 62
Study 33494132 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLB) (n = 20)
Number of subjects: 62
Study 34588230 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural security training for hospital staff and local, trial-specific, Aboriginal Brain Injury Coordinators supporting participants
Number of subjects: 312
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender-based violence (GBV) experienced by FEWs
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional abuse
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced substance use
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical abuse
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced sex
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Victimization by clients
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Victimization by others
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in beer gardens
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in restaurants/cafés
Number of subjects: 600
Study 32799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher acceptance of violence against women
Number of subjects: 600
Study 32284339 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Number of subjects: 20
Study 32284339 — intervention group
Group type: COMPARATOR
Intervention: Sham feedback
Number of subjects: 20
Study 34052458 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy evaluation using the Rapid Estimate of Adult Literacy in Medicine (REALM)
Number of subjects: 179
Study 32843581 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 slip-like treadmill perturbation trials
Number of subjects: 45
Study 32843581 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 slip-like treadmill perturbation trials
Number of subjects: 45
Study 32843581 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 35648294 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg implanted into the socket
Number of subjects: 15
Study 35648294 — intervention group
Group type: COMPARATOR
Intervention: Control site (no simvastatin)
Number of subjects: 15
Study 33431491 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of CNM-Au8 once daily for 36 weeks
Number of subjects: 0
Study 33431491 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study 36239783 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS combined with PPI for 12 weeks
Number of subjects: 70
Study 36239783 — intervention group
Group type: COMPARATOR
Intervention: PPI alone for 12 weeks
Number of subjects: 70
Study 32935199 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group (serum levels of Ti, Al, V)
Number of subjects: 19
Study 32935199 — intervention group
Group type: COMPARATOR
Intervention: Low-risk group (control)
Number of subjects: 19
Study 32935199 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between high-risk and low-risk groups
Number of subjects: 19
Study 32998143 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg monotherapy
Number of subjects: 75
Study 32998143 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone 50 mg monotherapy
Number of subjects: 75
Study 32998143 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone/Ramipril 50/10 mg combination therapy
Number of subjects: 75
Study 32998143 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study 36123724 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate injection (2 ml)
Number of subjects: 180
Study 36123724 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (2 ml)
Number of subjects: 180
Study 33045140 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal capsaicin 0.1mM
Number of subjects: 22
Study 33045140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 32173018 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual weaning protocol
Number of subjects: 36
Study 32173018 — intervention group
Group type: COMPARATOR
Intervention: Abrupt weaning protocol
Number of subjects: 36
Study 32173018 — intervention group
Group type: EXPERIMENTAL
Intervention: High concentrate intake (>350 g/d)
Number of subjects: 36
Study 32173018 — intervention group
Group type: COMPARATOR
Intervention: Low concentrate intake (≤350 g/d)
Number of subjects: 36
Study 35243319 — intervention group
Group type: EXPERIMENTAL
Intervention: Parotid gland irradiation (2x6 Gy with one week interval)
Number of subjects: 31
Study 35243319 — intervention group
Group type: EXPERIMENTAL
Intervention: Submandibular gland irradiation (2x6 Gy with one week interval)
Number of subjects: 31
Study 35243319 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation (placebo)
Number of subjects: 31
Study 32015491 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥ 12% VAF TP53 mutations
Number of subjects: 499
Study 32015491 — intervention group
Group type: COMPARATOR
Intervention: <12% VAF TP53 mutations
Number of subjects: 499
Study 32015491 — intervention group
Group type: EXPERIMENTAL
Intervention: Biallelic BIRC3 lesions (mutation and deletion)
Number of subjects: 499
Study 32015491 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutated MAPK-ERK genes
Number of subjects: 499
Study 34489274 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational regimens in TB-PRACTECAL trial
Number of subjects: 0
Study 34489274 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous blood samples collected at various time points
Number of subjects: 0
Study 34489274 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum samples collected at baseline and monthly to week 24
Number of subjects: 0
Study 34489274 — intervention group
Group type: EXPERIMENTAL
Intervention: Full blood count, urea and electrolytes, liver function tests, lipase, ECGs and ophthalmology examinations
Number of subjects: 0
Study 34489274 — intervention group
Group type: EXPERIMENTAL
Intervention: PK and PKPD models developed for each drug
Number of subjects: 0
Study 34516535 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted ferritin concentrations using a higher ferritin cut-off point (<30 g/L)
Number of subjects: 1375
Study 34516535 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted ferritin concentrations excluding subjects with inflammation (C-reactive protein >5 mg/L or a1-acid glycoprotein >1 g/L)
Number of subjects: 1375
Study 34516535 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted ferritin concentrations using a mathematical correction factor based on C-reactive protein or a1-acid glycoprotein
Number of subjects: 1375
Study 34516535 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted ferritin concentrations using regression correction method proposed by the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia Group
Number of subjects: 1375
Study 34516535 — intervention group
Group type: COMPARATOR
Intervention: Unadjusted prevalence of iron deficiency
Number of subjects: 1375
Study 34516535 — intervention group
Group type: COMPARATOR
Intervention: Proportion of children with inflammation according to C-reactive protein concentrations >5 mg/L
Number of subjects: 1375
Study 34516535 — intervention group
Group type: COMPARATOR
Intervention: Proportion of children with inflammation according to a1-acid glycoprotein concentrations >1 g/L
Number of subjects: 1375
Study 34516535 — intervention group
Group type: COMPARATOR
Intervention: Percentage of children with high concentrations of at least one inflammatory biomarker
Number of subjects: 1375
Study 32217654 — intervention group
Group type: COMPARATOR
Intervention: INBUILD trial (n=331)
Number of subjects: 754
Study 32217654 — intervention group
Group type: COMPARATOR
Intervention: INPULSIS trials (n=423)
Number of subjects: 754
Study 35840306 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic administration 1 week prior to tissue culture collection
Number of subjects: 0
Study 35840306 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic administration 3 days prior to tissue culture collection
Number of subjects: 0
Study 35840306 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic administration 1 day prior to tissue culture collection
Number of subjects: 0
Study 35840306 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic administration 1 day after tissue culture collection
Number of subjects: 0
Study 35840306 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 35840306 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-related markers (white blood cell count, C reactive protein, erythrocyte sedimentation rate, vital signs, length of hospital stay)
Number of subjects: 0
Study 33549078 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal palpation
Number of subjects: 65
Study 33549078 — intervention group
Group type: COMPARATOR
Intervention: Transabdominal ultrasound
Number of subjects: 65
Study 35301929 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3‐‐rich beetroot juice (BR)
Number of subjects: 12
Study 35301929 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3‐‐depleted beetroot juice (PL)
Number of subjects: 12
Study 35301929 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; water)
Number of subjects: 12
Study 32331584 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 44
Study 32331584 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 44
Study 36322844 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin with doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide
Number of subjects: 587
Study 36322844 — intervention group
Group type: COMPARATOR
Intervention: Standard pediatric regimen of doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide
Number of subjects: 587
Study 34431929 — intervention group
Group type: EXPERIMENTAL
Intervention: Floral therapy (Five Flower floral essence)
Number of subjects: 164
Study 34431929 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control Group)
Number of subjects: 164
Study 32196393 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-occluded water resistance ventilation mask (30 min session)
Number of subjects: 24
Study 32196393 — intervention group
Group type: COMPARATOR
Intervention: Traditional water resistance approach (30 min session)
Number of subjects: 24
Study 35287713 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Calorie Restriction (ICR) - 5:2 diet
Number of subjects: 147
Study 35287713 — intervention group
Group type: COMPARATOR
Intervention: Continuous Calorie Restriction (CCR)
Number of subjects: 147
Study 33567733 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) enriched with extra-virgin olive oil or nuts
Number of subjects: 4189
Study 33567733 — intervention group
Group type: COMPARATOR
Intervention: Control diet (low-fat diet)
Number of subjects: 4189
Study 34785108 — intervention group
Group type: EXPERIMENTAL
Intervention: Yindan Jiedu granules (YDJDG)
Number of subjects: 262
Study 32213777 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone stent placement
Number of subjects: 78
Study 32213777 — intervention group
Group type: COMPARATOR
Intervention: No stent
Number of subjects: 78
Study 34044375 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond XT containing 1% chitosan NPs and 1% TiO2 NPs
Number of subjects: 24
Study 34044375 — intervention group
Group type: COMPARATOR
Intervention: Transbond XT (control group)
Number of subjects: 24
Study 32542040 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier age at menarche
Number of subjects: 114883
Study 32542040 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at first sexual intercourse
Number of subjects: 114883
Study 35962639 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam/Ketamine (30 to 50 μg/kg and 0.25 to 1 mg/kg)
Number of subjects: 17
Study 35962639 — intervention group
Group type: COMPARATOR
Intervention: Propofol/Fentanyl (0.5 to 1 mg/kg and 0.5 to 1 mg/kg)
Number of subjects: 17
Study 35962639 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam/Ketamine
Number of subjects: 17
Study 35962639 — intervention group
Group type: COMPARATOR
Intervention: Propofol/Fentanyl
Number of subjects: 17
Study 34821547 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone plus misoprostol
Number of subjects: 711
Study 34821547 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus misoprostol
Number of subjects: 711
Study 35389583 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light and radiofrequency therapy
Number of subjects: 9
Study 35389583 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 9
Study 34008857 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 4 mg
Number of subjects: 12
Study 34008857 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 12
Study 34008857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 35171682 — intervention group
Group type: EXPERIMENTAL
Intervention: Children who died (n = 92)
Number of subjects: 184
Study 35171682 — intervention group
Group type: COMPARATOR
Intervention: Children who survived (n = 92)
Number of subjects: 184
Study 34029160 — intervention group
Group type: EXPERIMENTAL
Intervention: Metsulfuron applied at 0 days before sowing (DBS)
Number of subjects: 4
Study 34029160 — intervention group
Group type: EXPERIMENTAL
Intervention: Metsulfuron applied at 15 DBS
Number of subjects: 4
Study 34029160 — intervention group
Group type: EXPERIMENTAL
Intervention: Metsulfuron applied at 30 DBS
Number of subjects: 4
Study 34029160 — intervention group
Group type: EXPERIMENTAL
Intervention: Metsulfuron applied at 45 DBS
Number of subjects: 4